A graduate of Georgetown University, Dr. Pater received his MD from Case Western Reserve University in Cleveland, Ohio, and completed specialty training in hematology and oncology. In addition, he obtained an MSc in Clinical Epidemiology and Biostatistics from McMaster University.

Dr. Pater was Director of CCTG (formerly NCIC Clinical Trials Group) from 1980 to 2007, where he took an active part in the development, execution and analysis of over 100 cooperative cancer trials. He was Head of the Department of Epidemiology and Biostatistics (now Public Health Sciences) from 1987 to 2000. He held the Edith Eisenhauer Chair in Clinical Cancer Research at Queen’s University from 2000 to 2007. Dr Pater has served on numerous research advisory bodies and selection committees in Ontario, in Canada and internationally, particularly in the United Kingdom.

On his retirement from Canadian Cancer Trials Group, Dr. Pater assumed the position of Emeritus Professor at Queen’s and subsequently completed a three-year term at Cancer Care Ontario as the Vice-President of Clinical and Translational Research. In the Fall of 2013, he returned to the CCTG on a part time basis as a Senior Investigator.

Dr. Pater is the chair of the Protocol Committee and member of the Management Committee for the Canadian Cancer Trials Network. He is a member of the PDQ Adult Treatment Board of the US National Cancer Institute. He serves on the International Registration Review Committee for the UKCRC Registered Clinical Trials Unit Program and on the International Advisory Committee to the Leeds Clinical Trials Research Unit.

Areas of expertise: Trial Methodology, Quality of Life, Lung and Breast Cancers

Research interests: Clinical research methods; data-sharing

For a full list of publications please visit PubMed.